Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
9.55
0.00 (0.00%)
At close: Sep 4, 2026, 4:00 PM EDT
9.20
-0.35 (-3.66%)
Pre-market: Sep 8, 2026, 6:17 AM EDT
Puma Biotechnology Market Cap
Puma Biotechnology has a market cap or net worth of $492.97 million as of September 4, 2026. Its market cap has increased by 90.78% in one year.
Market Cap
492.97M
Enterprise Value
403.89M
1-Year Change
90.78%
Ranking
Category
Stock Price
$9.55
ChartMarket Cap Chart
Since April 24, 2012, Puma Biotechnology's market cap has increased from $280.60M to $492.97M, an increase of 75.68%. That is a compound annual growth rate of 4.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 493.00M | 64.44% |
| Dec 31, 2025 | 299.80M | 100.27% |
| Dec 31, 2024 | 149.70M | -27.33% |
| Dec 29, 2023 | 206.00M | 6.68% |
| Dec 30, 2022 | 193.10M | 55.35% |
| Dec 31, 2021 | 124.30M | -69.53% |
| Dec 31, 2020 | 408.00M | 19.68% |
| Dec 31, 2019 | 340.90M | -56.07% |
| Dec 31, 2018 | 776.00M | -79.08% |
| Dec 29, 2017 | 3.71B | 228.21% |
| Dec 30, 2016 | 1.13B | -55.55% |
| Dec 31, 2015 | 2.54B | -55.43% |
| Dec 31, 2014 | 5.71B | 92.11% |
| Dec 31, 2013 | 2.97B | 452.60% |
| Dec 31, 2012 | 537.50M | 91.55% |
| Apr 24, 2012 | 280.60M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 519.43M |
| Kyverna Therapeutics | 510.21M |
| Prothena Corporation | 504.13M |
| Editas Medicine | 496.06M |
| Rezolute | 478.46M |
| Relmada Therapeutics | 472.55M |
| Ginkgo Bioworks Holdings | 468.01M |
| Atea Pharmaceuticals | 467.59M |